Evidence map›Paper›PMID 37026630›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer.

Chih-Hung Chung, Chun-Yu Lin, Chih-Yu Chen, Chun-Wei Hsueh, Yao-Wen Chang, Chen-Chi Wang, Pen-Yuan Chu, Shyh-Kuan Tai, Muh-Hwa Yang

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chih-Hung ChungTaiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, 115201, Taiwan.ORCID 0000-0002-7010-9701
Chun-Yu LinDepartment of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, 300093, Taiwan.
Chih-Yu ChenCancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Chun-Wei HsuehInstitute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300093, Taiwan.
Yao-Wen ChangCancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Chen-Chi WangSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Pen-Yuan ChuSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Shyh-Kuan TaiSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Muh-Hwa YangTaiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, 115201, Taiwan.ORCID 0000-0002-8918-1244
National Yang Ming Chiao Tung University · TW

Funding

Division of Experimental Surgery, Department of Surgery of Taipei Veterans General HospitalGenomics Center for Clinical and Biotechnological Applications of the Cancer Progression Research CenterHigher Education Sprout Project by the Ministry of EducationMinistry of Health and Welfare, Center of Excellence for Cancer Research MOHW110-TDU-B-211-144019Ministry of Science and Technology 108-2314-B-010-046Ministry of Science and Technology 111-2314-B-A49-030-MY3Ministry of Science and Technology 111-2314-B-A49-061-MY3Ministry of Science and Technology 111-2320-B-A49-007Ministry of Science and Technology 111-2636-B-A49-010Ministry of Science and Technology MOST 108-2319-B-010-001Ministry of Science and Technology MOST 109-2740-B-010-002Ministry of Science and Technology MOST 110-2740-B-A49A-501Ministry of Science and Technology NSTC 111-2321-B-A49 -007National Core Facility for BiopharmaceuticalsNational Health Research Institutes NHRI-EX109-10919BIResearch Center Program of Featured Areas Research Center ProgramTaipei Veterans General Hospital V110C-139
6 · The paper itself

Abstract

As a type of immunogenic cell death, ferroptosis participates in the creation of immunoactive tumor microenvironments. However, knowledge of spatial location of tumor cells with ferroptosis signature in tumor environments and the role of ferroptotic stress in inducing the expression of immune-related molecules in cancer cells is limited. Here the spatial association of the transcriptomic signatures is demonstrated for ferroptosis and inflammation/immune activation located in the invasive front of head and neck squamous cell carcinoma (HNSCC). The association between ferroptosis signature and inflammation/immune activation is more prominent in HPV-negative HNSCC compared to HPV-positive ones. Ferroptotic stress induces PD-L1 expression through reactive oxygen species (ROS)-elicited NF-κB signaling pathway and calcium influx. Priming murine HNSCC with the ferroptosis inducer sensitizes tumors to anti-PD-L1 antibody treatment. A positive correlation between the ferroptosis signature and the active immune cell profile is shown in the HNSCC samples. This study reveals a subgroup of ferroptotic HNSCC with immune-active signatures and indicates the potential of priming HNSCC with ferroptosis inducers to increase the antitumor efficacy of immune checkpoint inhibitors.

Indexed as

FerroptosisHead and Neck NeoplasmsPapillomavirus InfectionsAnimalsImmune Checkpoint InhibitorsMiceSquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentImmune Checkpoint Inhibitorsferroptosishead and neck cancerprogrammed death ligand 1

Identifiers

PMID37026630
PMCPMC10214241
OpenAlexW4362692185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.